The global western blotting market size is expected to reach USD 2.78 billion by 2030, registering a CAGR of 6.01% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.
Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.
Request a free sample copy or view report summary: Western Blotting Market Report
The consumables segment dominated the market in 2024. Consumables such as reagents, buffers, antibodies, conjugates, kits, membranes, and filter-out sheets can be customized for a single use.
The instrument segment is expected to register a significant CAGR of 4.66% over the forecast period.
The biomedical & biochemical research segment dominated the industry with a revenue share of 61.59% in 2024.
The academic & research institute segment dominated the market with a revenue share of 35.15% in 2024. The segment has been the leading end-use segment in the market due to its widespread use of western blotting for fundamental research, protein studies, and biomolecular analysis.
Grand View Research has segmented the global western blotting market on the basis of product, application, end use, and region:
Western Blotting Product Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Gel Electrophoresis Instruments
Blotting Systems
Semi-Dry Blotting Instruments
Wet Blotting Instruments
Imagers
Chemiluminescent Imagers
Fluorescent Imagers
Others
Consumables
Reagents
Kits
Western Blotting Application Outlook (Revenue, USD Million, 2018 - 2030)
Biomedical & Biochemical Research
Disease Diagnostics
Agriculture
Others
Western Blotting End Use Outlook (Revenue, USD Million, 2018 - 2030)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Centers
Others
Western Blotting Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
APAC
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Western Blotting Market
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
LI-COR, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd.
Bio-Techne Corporation
GE HealthCare
QIAGEN
Advansta Inc.
Cell Signaling Technology, Inc.
"The quality of research they have done for us has been excellent..."